Thyroid Peroxidase Antibody

Test Name
Thyroid Peroxidase Antibody
Aliases
Anti-TPO, ATPO
Provincial Mnemonic
THYPAB
LOINC Test Code
8099-4
Description and Primary Use
Unlike autoantibodies to thyroglobulin (anti-Tg), autoantibodies to TPO are potentially deleterious and may have a pathogenic role in (destructive) autoimmine thyroid disease. Anti-TPO antibodies are found often in conjunction with anti-Tg in the majority of cases of Hashimoto's thyroiditis, Primary Myxedema, and Graves' disease. The relationship of autoimmine thyroid disease to pregnancy has been the subject of considerable interest with the recognition of the postpartum thyroid disease syndromes. Anti-TPO antibodies are demonstrable in most cases of postpartum thyroiditis and it has been found that the presence of autoantibody in early pregnancy was associated with a high risk of asymptomatic postpartum hypothyroidism. It is common to find anti-TPO antibodies in the absence of autoantibodies to thyroglobulin, particularly in patients with small goitres and up to 64% of cases of autoimmune hypothyroidism have been reported to be associated with anti-TPO antibodies alone. In addition, anti-TPO antibodies are frequently found in patients with other autoimmune diseases such as Rheumatoid Arthritis, Addison's Disease and Type I Diabetes. They are also detectable at low levels in up to 20% of asymptomatic individuals, particularly the elderly and more often in women than in men, although the clinical significance of these autoantibodies is unclear.
Reorder interval
90 Days
TAT
≤3 Days
Test Cost
Not Available
Tier
1 - General Availability
Ordering Requirements (Restrictions / Conditions)

No Restrictions

Required Consultations
None
Algorithms and Guidelines

None

Special Patient Preparation

None

Special Collection / Transport / Processing Requirements

No special requirement

Criteria for Rejection

Based on specimen condition and stability

Laboratory Service Area
Clinical Chemistry
Performing Laboratory / Site
Category 4 Laboratory (HSC only)
Last Updated
18-Sep-19